RxDoctor Payments Data

Richard Rupp

Adolescent Medicine · Galveston, TXNPI 1700893625

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,147 of the $20,135 with a category attached, or 75.2%. GSK accounts for 60.3% of it on its own, with 3 other manufacturers making up the rest. Among adolescent medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,135in general payments, 2019–2025

Across 45 payments — averaging $447.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$12K
  • Merck$5K
  • Modernatx, Inc.$2K
  • Pfizer$2K
$7,694,134in research payments, 2019–2025

Across 1,012 payments — averaging $7602.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$4.4M
  • Merck$2.3M
  • GSK$475K
  • Modernatx, Inc.$307K
  • Sanofi Pasteur Inc.$216K

What the payments were for

  • Consulting fees$15,14775%
  • Travel & lodging$3,07115%
  • Food & beverage$1,8989%
  • Gifts$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK11$12,147
Merck21$4,548
Modernatx, Inc.7$1,728
Pfizer6$1,712

How this compares

$20,135 in reported general payments places this provider in the 95th percentile of 68 adolescent medicine providers in Texas.

See all adolescent medicine providers in Texas

Other adolescent medicine in Galveston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →